Praxis Precision Medicines (PRAX)

Praxis Precision Medicines Stock Analysis & Ratings

PRAX Stock Chart & Stats

Day’s Range$0 - $0
52-Week Range$7.25 - $23.56
Previous Close$10.95
Average Volume (3M)273.22K
Market Cap$498.35M
P/E Ratio-2.3
Next EarningsAug 15, 2022
Next Dividend Ex-DateN/A
Dividend YieldN/A
Smart Score5
EPS (TTM)-4.69



P/E Ratio Range

The price to earnings ratio. This is used by investors to assess a stock’s market price relative to its earnings.



What was Praxis Precision Medicines’s price range in the past 12 months?
Praxis Precision Medicines lowest stock price was $7.25 and its highest was $23.56 in the past 12 months.
    What is Praxis Precision Medicines’s market cap?
    Praxis Precision Medicines’s market cap is $498.35M.
      What is Praxis Precision Medicines’s price target?
      The average price target for Praxis Precision Medicines is $56.50. This is based on 3 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
      The highest analyst price target is $65.00 ,the lowest forecast is $48.00. The average price target represents 415.98% Increase from the current price of $10.95.
        What do analysts say about Praxis Precision Medicines?
        Praxis Precision Medicines’s analyst rating consensus is a ‘Strong Buy. This is based on the ratings of 3 Wall Streets Analysts.
          When is Praxis Precision Medicines’s upcoming earnings report date?
          Praxis Precision Medicines’s upcoming earnings report date is Aug 15, 2022 which is in 89 days.
            How were Praxis Precision Medicines’s earnings last quarter?
            Praxis Precision Medicines released its earnings results on May 09, 2022. The company reported -$1.51 earnings per share for the quarter, missing the consensus estimate of -$1.305 by -$0.205.
              Is Praxis Precision Medicines overvalued?
              According to Wall Street analysts Praxis Precision Medicines’s price is currently Undervalued.
                Does Praxis Precision Medicines pay dividends?
                Praxis Precision Medicines does not currently pay dividends.
                What is Praxis Precision Medicines’s EPS estimate?
                Praxis Precision Medicines’s EPS estimate for its next earnings report is not yet available.
                How many shares outstanding does Praxis Precision Medicines have?
                Praxis Precision Medicines has 45,510,000 shares outstanding.
                  What happened to Praxis Precision Medicines’s price movement after its last earnings report?
                  Praxis Precision Medicines reported an EPS of -$1.51 in its last earnings report, missing expectations of -$1.305. Following the earnings report the stock price went up 24.628%.
                    Which hedge fund is a major shareholder of Praxis Precision Medicines?
                    Among the largest hedge funds holding Praxis Precision Medicines’s share is Moore Capital Management LP. It holds Praxis Precision Medicines’s shares valued at N/A.


                      Praxis Precision Medicines Stock Analysis

                      The Praxis Precision Medicines stock analysis is based on the TipRanks Smart Score which is derived from 8 unique data sets including Analyst recommendations, Crowd Wisdom, Hedge Fund Activity, Media Sentiment and multiple Technical stock factors. The Smart Score is a quantitative, data-driven rating system and does not include human intervention.
                      Learn more about TipRanks Smart Score

                      Company Description

                      Praxis Precision Medicines

                      Praxis Precision Medicines Inc is a clinical-stage biopharmaceutical company. The firm is engaged in developing therapies for patients and families affected by complex and debilitating brain disorders. The firm's pipeline covers PRAX-114, PRAX-944, PRAX-562, and PRAX-222 among others.

                      Similar Stocks
                      No data currently available

                      Popular Stocks

                      What's Included in PREMIUM?
                      Make informed decisions based on Top Analysts' activity
                      Know what industry insiders are buying
                      Get actionable alerts from top Wall Street Analysts
                      Find out before anyone else which stock is going to shoot up
                      Get powerful stock screeners & detailed portfolio analysis